Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Olmibite-Trio 40 Tablet

Prescription Icon
Prescription Required

Marketer

Medbiosquid Pharmaceuticals Pvt Ltd

Salt Composition

Olmesartan Medoxomil (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg)

Overview Olmibite-Trio 40 Tablet

HypertensionTriple 40mg tablets combine medications to manage high blood pressure unresponsive to single-drug therapy. This treatment lowers blood pressure, mitigating stroke and heart attack risks. Take HypertensionTriple 40mg with food, at the same time daily, as directed by your physician. Continue use until advised otherwise; discontinuation increases stroke/heart attack risk. The formulation includes a diuretic, increasing urination; avoid taking it within four hours of bedtime. Consistent use maximizes benefits, even if feeling well (high blood pressure is often asymptomatic). Common side effects: ankle swelling, headache, dizziness, fatigue, altered taste. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counteract potential dryness, thirst, and muscle weakness. Inform your doctor of liver/kidney issues, pregnancy, breastfeeding, and all other medications, especially cardiovascular drugs, before starting treatment. Regular monitoring of blood pressure, kidney function, electrolytes, and blood sugar is vital to ensure efficacy and safety.

Primary Ingredients of Olmibite-Trio 40 Tablet

No information provided. Please provide the text you wish to be rewritten.

Uses of Olmibite-Trio 40 Tablet

Elevated blood pressure

Major Benefits of Olmibite-Trio 40 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmibite-Trio 40 Tablet should be administered with a meal.

Common Side effects of Olmibite-Trio 40 Tablet:

  • Ankle swelling
  • Headache
  • Dizziness
  • Tiredness
  • Palpitations
  • Sleepiness
  • Increased blood uric acid
  • Glucose intolerance
  • Taste change
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Upset stomach
  • Altered blood lipid level

How to use Olmibite-Trio 40 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Olmibite-Trio 40 Tablet with a meal.

How Olmibite-Trio 40 Tablet works:

Olmibite-Trio 40 Tablet combines olmesartan medoxomil, cilnidipine, and chlorthalidone to manage hypertension. Olmesartan medoxomil, an angiotensin receptor blocker (ARB), and cilnidipine, a calcium channel blocker (CCB), act synergistically to vasodilate, thus reducing blood pressure. Chlorthalidone, a diuretic, facilitates fluid and electrolyte excretion, contributing to lowered blood pressure via diuresis and additional vasodilation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Olmibite-Trio 40 tablets and alcohol may result in pronounced somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Olmibite-Trio 40 Tablet is contraindicated during pregnancy due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Olmibite-Trio 40 Tablet with breastfeeding are currently lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Olmibite-Trio 40 Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Olmibite-Trio 40 Tablet, potentially requiring dosage modification. Physician consultation is advised; its use is generally discouraged in such cases.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Olmibite-Trio 40 Tablet; dosage modification may be necessary. Medical advice is recommended. Olmibite-Trio 40 Tablet is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Olmibite-Trio 40 Tablet :

For omitted Olmibite-Trio 40 Tablet doses, administer the medication as promptly as feasible. If, however, your next scheduled dose is imminent, forgo the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Olmibite-Trio 40 Tablet

LabelValue
Developing Habits No.
Treatment Category HEART
Olmibite-Trio 40 Tablet
225
MRP 260
13% off